Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Christopher J. Logothetis
Based on 124 articles published since 2009
(Why 124 articles?)
||||
Expertise Level
The expertise of Christopher J. Logothetis ranks in the
  • Top 0.025%
  • ... of 131,908 published authors worldwide on Prostatic Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 124 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Logothetis, C J   ·   Logothetis, Chris   ·   Logothetis, C   ·   Logothetis, Christopher   ·   Logothetis, Christopher J
Work Locations
Details
Most likely:    University of Texas Houston   Contact    
2019
  • Department of Urology, University Hospitals Leuven, Leuven, Belgium; Nuclear Medicine & Molecular Imaging, KU Leuven, Leuven, Belgium. Electronic address: · Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA, USA. · Urology Service at the Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Oncology in the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, MD, USA. · The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Urology, Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, Quebec, Canada. · Dana-Farber Cancer Institute, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 30286948
  • Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, 1881 East Road, Unit 1907, Houston, TX, 77054, USA. · Department of Bioengineering, Rice University, Houston, TX, USA. · Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, 1881 East Road, Unit 1907, Houston, TX, 77054, USA. · Pubmed 29748904
2018
  • University of Texas-MD Anderson Cancer Center, Houston, TX, USA. · Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY, USA. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Weston Park Hospital, University of Sheffield, Sheffield, UK. · Pubmed 29380085
  • Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA. Electronic address: · The Institute of Cancer Research, London, UK. · Hematology-Oncology Division, Beth Israel Deaconess Medical Center, Boston, MA, USA. · Department of Surgery & Cancer, Imperial College London, Imperial Centre for Translational & Experimental Medicine (ICTEM), Hammersmith Hospital Campus, London, UK. · Department of Molecular & Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Department of Urologic Sciences, University of British Columbia, The Vancouver Prostate Centre, Vancouver, BC, Canada. · Division of Clinical Studies, The Institute of Cancer Research, London, UK. · Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA, USA. · Department of Urology, University of California Davis, Sacramento, CA, USA. · Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA; Department of Urology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA; Department of Hematology/Medical Oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. · Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan. · McDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, TX, USA. · Department of Medicine, Carbone Cancer Center, University of Wisconsin, Madison, WI, USA. · Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Urologic Surgery, Vanderbilt Prostate Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA. · Department of Medicine, University of Washington and VAPSHCS GRECC, Seattle, WA, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Dame Roma Mitchell Cancer Research Laboratories and Freemasons Foundation Centre for Men's Health, Adelaide Medical School, The University of Adelaide, SA, Australia. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA. · Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA; Department of Urology, University of Minnesota, Minneapolis, MN, USA. Electronic address: · Department of Urology, UT Southwestern Medical Center at Dallas, Dallas, TX, USA; Department of Urology and Pharmacology, UT Southwestern Medical Center at Dallas, Dallas, TX, USA. Electronic address: · Pubmed 29258679
  • The Institute of Cancer Research, London, SW7 3RP, UK. · MRC Biostatistics Unit, University of Cambridge, Robinson Way, Cambridge, CB2 0SR, UK. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Cambridge, CB1 8RN, UK. · Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0QQ, UK. · Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, 44106-7219, USA. · Seidman Cancer Center, University Hospitals, Cleveland, OH, 44106, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, 20892, USA. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, 90015, USA. · Institute of Population Health, University of Manchester, Manchester, M13 9PL, UK. · Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK. · Epidemiology Research Program, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA. · SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA. · CHRISTUS Santa Rosa Hospital - Medical Center, San Antonio, TX, 78229, USA. · Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology, Brisbane, QLD, 4059, Australia. · Translational Research Institute, Brisbane, QLD, 4102, Australia. · Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, 4222, Australia. · Cancer Council Queensland, Fortitude Valley, QLD, 4006, Australia. · Chris O'Brien Lifehouse (COBLH), Camperdown, Sydney, NSW, 2010, Australia. · Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia. · Dame Roma Mitchell Cancer Research Centre, University of Adelaide, Adelaide, SA, 5005, Australia. · Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia. · Prostate Cancer Translational Research Program, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Department of Medical Epidemiology and Biostatistics, Karolinska Institute, SE-171 77, Stockholm, Sweden. · Department of Molecular Medicine and Surgery, Karolinska Institutet, and Department of Urology, Karolinska University Hospital, 171 76, Stockholm, Sweden. · Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, 182 88, Stockholm, Sweden. · Centre for Cancer Genetic Epidemiology, Department of Oncology, Strangeways Laboratory, University of Cambridge, Cambridge, CB1 8RN, UK. · Department of Applied Health Research, University College London, London, WC1E 7HB, UK. · Institute of Biomedicine, University of Turku, FI-20014, Turku, Finland. · Tyks Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, 20521, Turku, Finland. · Department of Urology, Tampere University Hospital, University of Tampere, Kalevantie 4, FI-33014, Tampere, Finland. · Department of Epidemiology, School of Health Sciences, University of Tampere, FI-33014, Tampere, Finland. · Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, SE-171 77, Stockholm, Sweden. · Division of Cancer Sciences, Manchester Academic Health Science Centre, Radiotherapy Related Research, Manchester NIHR Biomedical Research Centre, The Christie Hospital NHS Foundation Trust, University of Manchester, Manchester, M13 9PL, UK. · University of Cambridge Department of Oncology, Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB1 8RN, UK. · Department of Epidemiology, Harvard School of Public Health, Boston, MA, 02115, USA. · Washington University School of Medicine, St. Louis, MO, 63110, USA. · GRC N°5 ONCOTYPE-URO, UPMC Univ Paris 06, Tenon Hospital, F-75020, Paris, France. · CeRePP, Tenon Hospital, F-75020, Paris, France. · Department of Molecular Medicine, Aarhus University Hospital, 8200, Aarhus N, Denmark. · Department of Clinical Medicine, Aarhus University, 8200, Aarhus N, Denmark. · Department of Urology, Aarhus University Hospital, 8200, Aarhus N, Denmark. · Department of Medical Genetics, Oslo University Hospital, 0424, Oslo, Norway. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0QQ, UK. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, CB2 0RE, UK. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, OX1 2JD, UK. · School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. · Faculty of Medical Science, John Radcliffe Hospital, University of Oxford, Oxford, OX1 2JD, UK. · Medical Research Council (MRC) Integrative Epidemiology Unit, University of Bristol, Bristol, BS8 2BN, UK. · National Institute for Health Research (NIHR) Biomedical Research Centre, University of Bristol, Bristol, BS8 1TH, UK. · Cancer Epidemiology, Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK. · Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, ON, M5G 2M9, Canada. · Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. · Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029-5674, USA. · Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, 14620, USA. · Professor of Pathology and Pediatrics, Albert Einstein College of Medicine, Bronx, NY, 10461, USA. · Centre for Molecular Oncology, Barts Cancer Institute, John Vane Science Centre, Queen Mary University of London, London, EC1M 6BQ, UK. · Second Military Medical University, Shanghai, 200433, P. R. China. · Wuxi Second Hospital, Nanjing Medical University, Wuxi, Jiangzhu, 214003, China. · Department of Urology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, 200032, China. · The People's Hospital of Liaoning Province and The People's Hospital of China Medical University, Shenyang, 110001, China. · Department of Urology, Zhongshan Hospital, Fudan University Medical College, Shanghai, 200032, China. · Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, VIC, 3004, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, 3010, Australia. · Precision Medicine, School and Clinical Sciences at Monash Health, Monash University, Clayton, VIC, 3168, Australia. · Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia. · Division of Urologic Surgery, Brigham and Womens Hospital, Boston, MA, 02115, USA. · Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica, CIBERER, IDIS, Santiago de Compostela, 15706, Spain. · Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, 15706, Santiago de Compostela, Spain. · Division of Family Medicine, Department of Neurobiology, Care Science and Society, Karolinska Institutet, Huddinge, SE-171 77, Stockholm, Sweden. · Scandinavian Development Services, 182 33, Danderyd, Sweden. · Centre for Research in Environmental Epidemiology (CREAL), Barcelona Institute for Global Health (ISGlobal), 08003, Barcelona, Spain. · CIBER Epidemiología y Salud Pública (CIBERESP), 28029, Madrid, Spain. · IMIM (Hospital del Mar Research Institute), 08003, Barcelona, Spain. · Universitat Pompeu Fabra (UPF), 08002, Barcelona, Spain. · University of Cantabria-IDIVAL, 39005, Santander, Spain. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, 02184, USA. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, 33612, USA. · School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA. · Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109-1024, USA. · Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, 98195, USA. · International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 70-115, Szczecin, Poland. · National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 20892, USA. · Faculty of Health and Medical Sciences, University of Copenhagen, 2200, Copenhagen, Denmark. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2200, Copenhagen, Denmark. · Department of Urology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2200, Copenhagen, Denmark. · Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, Copenhagen University Hospital, DK-2730, Herlev, Denmark. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), D-69120, Heidelberg, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), D-69120, Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120, Heidelberg, Germany. · Saarland Cancer Registry, 66119, Saarbrücken, Germany. · Institute for Human Genetics, University Hospital Ulm, 89075, Ulm, Germany. · Department of Urology, University Hospital Ulm, 89075, Ulm, Germany. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Cancer Prevention Institute of California, Fremont, CA, 94538, USA. · Department of Health Research & Policy (Epidemiology) and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305-5101, USA. · Department of Genetics, Portuguese Oncology Institute of Porto, 4200-072, Porto, Portugal. · Biomedical Sciences Institute (ICBAS), University of Porto, 4050-313, Porto, Portugal. · Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, 91010, USA. · Ghent University, Faculty of Medicine and Health Sciences, Basic Medical Sciences, B-9000, Gent, Belgium. · Department of Radiotherapy, Ghent University Hospital, B-9000, Gent, Belgium. · Department of Surgery, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia. · Cancer Research Malaysia (CRM), Outpatient Centre, Subang Jaya Medical Centre, 47500, Subang Jaya, Selangor, Malaysia. · Department of Urology, University of Washington, Seattle, WA, 98195, USA. · Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, D-20246, Hamburg, Germany. · Division of Medical Oncology, Urogenital Unit, Department of Oncology at the University Hospital Centre Zagreb, Šalata 2, 10000, Zagreb, Croatia. · Department of Urology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Šalata 2, 10000, Zagreb, Croatia. · Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, 1431, Sofia, Bulgaria. · Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, T6G 1Z2, Canada. · Division of Radiation Oncology, Cross Cancer Institute, Edmonton, AB, T6G 1Z2, Canada. · Department of Urology and Alexandrovska University Hospital, Medical University of Sofia, 1431, Sofia, Bulgaria. · Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, BE-3000, Leuven, Belgium. · Department of Urology, University Hospitals Leuven, BE-3000, Leuven, Belgium. · Southampton General Hospital, The University of Southampton, Southampton, SO16 6YD, UK. · Manchester Cancer Research Centre, Faculty of Biology Medicine & Health, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Health Innovation Manchester, University of Manchester, Manchester, M13 9WL, UK. · The University of Surrey, Guildford, Surrey, GU2 7XH, UK. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saúde, SERGAS, 15706, Santiago de Compostela, Spain. · Moores Cancer Center, University of California San Diego, La Jolla, CA, 92037, USA. · Genetic Oncology Unit, CHUVI Hospital, Complexo Hospitalario Universitario de Vigo, Instituto de Investigación Biomédica Galicia Sur (IISGS), 36204, Vigo (Pontevedra), Spain. · Moores Cancer Center, Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA, 92093-0012, USA. · Department of Urology, Erasmus University Medical Center, 3015 CE, Rotterdam, The Netherlands. · Department of Clinical Chemistry, Erasmus University Medical Center, 3015 CE, Rotterdam, The Netherlands. · Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, 94807, Villejuif Cédex, France. · Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, 60201, USA. · Clinical Gerontology Unit, University of Cambridge, Cambridge, CB2 2QQ, UK. · Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, 84112, USA. · George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, 84148, USA. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA. · Division of Biomedical Statistics & Informatics, Mayo Clinic, Rochester, MN, 55905, USA. · Department of Epidemiology, University of Washington, Seattle, WA, 98195, USA. · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA. · Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, SW7 2AZ, UK. · Genomics England, Queen Mary University of London, Dawson Hall, Charterhouse Square, London, EC1M 6BQ, UK. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), D-69120, Heidelberg, Germany. · Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA. · Dana-Farber Cancer Institute, Boston, MA, 02215, USA. · Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK. · The Institute of Cancer Research, London, SW7 3RP, UK. · Pubmed 29892050
  • Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA. · Seidman Cancer Center, University Hospitals, Cleveland, OH, USA. · Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK. · Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA. · Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK. · Institute of Cancer Research, London, UK. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA. · Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica, CIBERER, IDIS, Santiago de Compostela, Spain. · Department of Oncology, Centre for Cancer Genetic Epidemiology, Strangeways Laboratory, University of Cambridge, Cambridge, UK. · Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK. · Warwick Medical School, University of Warwick, Coventry, UK. · Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA. · SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · CHRISTUS Santa Rosa Hospital-Medical Center, San Antonio, TX, USA. · Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia. · Australian Prostate Cancer Research Centre-Qld, Translational Research Institute, Brisbane, Queensland, Australia. · Menzies Health Institute of Queensland, Griffith University, Nathan, Queensland, Australia. · Cancer Council Queensland, Fortitude Valley, Queensland, Australia. · Chris O'Brien Lifehouse (COBLH), Camperdown, New South Wales, Australia. · Garvan Institute of Medical Research, Sydney, New South Wales, Australia. · Dame Roma Mitchell Cancer Research Centre, University of Adelaide, Adelaide, South Australia, Australia. · Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Program, Department of Anatomy and Developmental Biology, Monash University, Victoria, Australia. · Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Department of Urology, Karolinska University Hospital, Stockholm, Sweden. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. · Department of Clinical Sciences at Danderyds Hospital, Karolinska Institutet, Stockholm, Sweden. · Department of Applied Health Research, University College London, London, UK. · Institute of Biomedicine, University of Turku, Turku, Finland. · Tyks Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, Turku, Finland. · Department of Urology, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. · Department of Epidemiology, School of Health Sciences, University of Tampere, Tampere, Finland. · Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. · Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. · Division of Cancer Sciences, Manchester Cancer Research Centre, Manchester Academic Health Science Centre and Christie NHS Foundation Trust, University of Manchester, Manchester, UK. · Department of Oncology, Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge, UK. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Washington University School of Medicine, St. Louis, MO, USA. · UPMC Sorbonne Universités, GRC no. 5 ONCOTYPE-URO, Tenon Hospital, Paris, France. · CeRePP, Tenon Hospital, Paris, France. · Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark. · Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. · Department of Urology, Aarhus University Hospital, Aarhus, Denmark. · Department of Medical Genetics, Oslo University Hospital, Oslo, Norway. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK. · Cancer Research UK, Cambridge Research Institute, Cambridge, UK. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK, Faculty of Medical Science, John Radcliffe Hospital, University of Oxford, Oxford, UK. · School of Social and Community Medicine, University of Bristol, Bristol, UK. · Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. · Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Division of Urology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA. · Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA. · Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. · Second Military Medical University, Shanghai, China. · Wuxi Second Hospital, Nanjing Medical University, Wuxi, China. · Department of Urology, First Affiliated Hospital, Chongqing Medical University, Chongqing, China. · Department of Urology, Zhongshan Hospital, Fudan University Medical College, Shanghai, China. · People's Hospital of Liaoning Province, People's Hospital of China Medical University, Shenyang, China. · Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia. · Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia. · Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia. · Division of Urologic Surgery, Brigham and Womens Hospital, Boston, MA, USA. · Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain. · Division of Family Medicine, Department of Neurobiology, Care Science and Society, Karolinska, Institutet, Huddinge, Sweden. · Scandinavian Development Services, Danderyd, Sweden. · ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain. · CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. · IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Universitat Pompeu Fabra (UPF), Barcelona, Spain. · University of Cantabria-IDIVAL, Santander, Spain. · Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA. · Biostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, USA. · Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA. · International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Urology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · Saarland Cancer Registry, Saarbrücken, Germany. · Institute for Human Genetics, University Hospital Ulm, Ulm, Germany. · Department of Urology, University Hospital Ulm, Ulm, Germany. · Department of Genitourinary Medical Oncology, University of Texas-MD Anderson Cancer Center, Houston, TX, USA. · Cancer Prevention Institute of California, Fremont, CA, USA. · Department of Health Research & Policy (Epidemiology) and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. · Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal. · Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal. · Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, USA. · Faculty of Medicine and Health Sciences, Basic Medical Sciences, Ghent University, Ghent, Belgium. · Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium. · Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. · Cancer Research Malaysia (CRM), Outpatient Centre, Subang Jaya Medical Centre, Selangor, Malaysia. · Department of Urology, University of Washington, Seattle, WA, USA. · Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Oncology, Division of Medical Oncology, Urogenital Unit, University Hospital Centre Zagreb, Zagreb, Croatia. · Department of Urology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia. · Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, Sofia, Bulgaria. · Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada. · Division of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada. · Department of Urology and Alexandrovska University Hospital, Medical University of Sofia, Sofia, Bulgaria. · Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. · Department of Urology, University Hospitals Leuven, Leuven, Belgium. · University of Southampton, Southampton General Hospital, Southampton, UK. · Division of Cancer Sciences, Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Center, NIHR Manchester Biomedical Research Centre, Health Innovation Manchester, University of Manchester, Manchester, UK. · University of Surrey, Guildford, Surrey, UK. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saúde, SERGAS, Santiago de Compostela, Spain. · Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. · Genetic Oncology Unit, CHUVI Hospital, Instituto de Investigación Biomédica Galicia Sur (IISGS), Complexo Hospitalario Universitario de Vigo, Vigo, Spain. · Department of Family Medicine and Public Health, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. · Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands. · Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France. · Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA. · Clinical Gerontology Unit, University of Cambridge, Cambridge, UK. · Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA. · George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, USA. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA. · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. · Genomics England, Queen Mary University of London, London, UK. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA. · Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA. · Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. · Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA. · Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. · Institute of Cancer Research, London, UK. · Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 29892016
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai, China. · Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. · Michigan Center for Translational Pathology, Howard Hughes Medical Institute, Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 29138344
  • Department of Medical Oncology, Cantonal Hospital St. Gallen and University of Berne, Switzerland. Electronic address: · Department of Medical Oncology, The Institute of Cancer Research/Royal Marsden, London, UK. · Oregon Health & Science University Knight Cancer Institute, OR, USA. · Department of Medical Oncology, Weill Cornell Medicine, New York, NY, USA. · Department of Radiation Oncology, Genito Urinary Oncology, Prostate Brachytherapy Unit, Goustave Roussy, Paris, France. · Department of Radiation Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, USA. · Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, NY, USA. · Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. · Department of Urology, Gangnam Severance Hospital, Yonsei University Health System, Seoul, Korea. · Department of Urology, The Christie and Salford Royal Hospitals, Manchester, UK. · Department of Medical Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Department of Urology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil. · Department of Medical Oncology, Division of Haematology/Oncology, Columbia University Medical Center, New York, NY, USA. · Department of Clinical Oncology and Genetics, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · Department of Medical Oncology, University of Texas MD Anderson Cancer Center, TX, USA. · Department of Urology, University of California, Davis School of Medicine, CA, USA. · Department of Nuclear Medicine, Policlinico S. Orsola, Università di Bologna, Italy. · Department of Radiation Oncology, University of California, San Francisco, CA, USA. · Department of Medical Oncology, Gustave Roussy, University of Paris Sud, Paris, France. · Department of Surgery, Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and Health Sciences, Monash University. · Department of Urology, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. · Department of Clinical trials and Statistics, Duke University, Durham, NC, USA. · Department of Urology, University Hospital Köln, Köln, Germany. · Department of Medicine, Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, WA, USA. · Department of Clinical Oncology, Clinical Oncology Queen Elizabeth Hospital Birmingham and University of Birmingham, Birmingham, UK. · Department of Medical Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Clinical Oncology, Tampere University Hospital, Faculty of Medicine and Life Sciences, University of Tampere, Finland. · Department of Urology, American University of Beirut Medical Center, Beirut, Lebanon. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston, TX, USA. · Department of Medical Oncology Hospital Israelita Albert Einstein and Department of Medical Oncology Beneficência Portuguesa de São Paulo. · Department of Medical Oncology and Epidemiology, Vanderbilt University Medical Center, Division of Hematology/Oncology, Nashville, TN, USA. · Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Urology, University Hospital Nord St. Etienne, St. Etienne, France. · Department of Radiation Oncology, Tata Memorial Centre, Mumbai, India. · Department of Medical Oncology, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA. · Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium. · Department of Radiology, Mount Vernon Cancer Centre and Institute of Cancer Research, London, UK. · Department of Clinical Oncology, Royal Marsden NHS Foundation Trust, Sutton, UK. · Department of Pathology, University of Washington, WA, USA. · Department of Pathology, University of Bern and the Inselspital, Bern (CH). · Department of Medical Oncology, Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of, California, San Francisco, CA, USA. · Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Department of Medical Oncology, Tulane Cancer Center, New Orleans, LA, USA. · Department of Medical Oncology, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Centre, New York, NY, USA. · Department of Medical Oncology, Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Department of Medical Oncology, Massachusetts General Hospital Cancer Centre, Boston, MA, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. · Department of Medical Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada. · Department of Urology, Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Oncology and Haemato-oncology, Università degli Studi di Milano. Radiation Oncology 1, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Radiation Oncology, Klinik für Strahlentherapie und Radioonkologie des Universitätsklinikum Ulm, Albert-Einstein-Allee, Ulm, Germany. · Department of Medical Oncology, Cantonal Hospital St. Gallen and University of Berne, Switzerland. · Pubmed 28655541
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
  • From the University of Texas M.D. Anderson Cancer Center, Houston. · Pubmed 28745978
  • Tomasz M. Beer, Oregon Health and Science University, Portland, OR · Eugene D. Kwon, Mayo Clinic, Rochester, MN · Charles G. Drake, Johns Hopkins University, Baltimore, MD · Karim Fizazi, University of Paris-Sud, Villejuif · Gwenaelle Gravis, Institut Paoli-Calmettes, Marseille, France · Christopher Logothetis, University of Texas MD Anderson Cancer Center, Houston, TX · Vinod Ganju, Monash University, Melbourne, Victoria · Siobhan S. Ng, St John of God Hospital, Subiaco, Western Australia · Francis X. Parnis, Adelaide Cancer Centre, Adelaide, South Australia, Australia · Jonathan Polikoff, Southern California Permanente Medical Group, San Marcos, CA · Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada · Piotr Humanski, Niepubliczny Zaklad Opieki Zdrowotnej Specjalista, Kutno, Poland · Josep M. Piulats, Institut Català d'Oncologia, Barcelona · Javier Puente, Hospital Clínico San Carlos, Madrid, Spain · Pablo Gonzalez Mella, Instituto Oncologico, Viña del Mar · Pablo Gonzalez Mella, Fundación Arturo Lopez Pérez, Santiago, Chile · Dirk Jaeger, University Hospital, Heidelberg, Germany · Fabio A. Franke, Hospital de Caridade de Ijuí, Ijuí, Brazil · Roman Carvajal, Hospital Regional Valentin Gomez Farias, Zapopan, Mexico · Lisa Sengeløv, Herlev Hospital, Herlev, Denmark · M. Brent McHenry, Bristol-Myers Squibb, Wallingford, CT · Arvind Varma, DOCS Inc, New York, NY · Alfonsus J. van den Eertwegh, VU University Medical Center, Amsterdam · and Winald Gerritsen, Radboud University, Nijmegen, the Netherlands. · Pubmed 28034081
  • Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, 1365 Clifton Road NE, B4301, Atlanta, GA, 30322, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030-3721, USA. · Pubmed 28730293
  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, Taipei Medical University and Hospital, Taipei 110, Taiwan. · Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Medicine, McGill University, Montreal, QC, H3A 1G1, Canada. · Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: · Pubmed 28586644
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · ORBIT (Oncology Research for Biologics and Immunotherapy Translation), The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. · Pubmed 28536297
  • Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · The Immunotherapy Platform, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Janssen Oncology Therapeutic Area, Janssen Research and Development, LLC, Pharmaceutical Companies of Johnson &Johnson, Spring House, Pennsylvania, USA. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 28346412
  • Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, California. · Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, California. · Viterbi School of Engineering, University of Southern California, Los Angeles, California. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27702818
  • Ana Aparicio and Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX. · Pubmed 27937088
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College · David Nanus, NewYork Presbyterian Weill Cornell Medical Center · Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY · Walter M. Stadler, University of Chicago Medicine, Chicago, IL · Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA · Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC · Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD · Tomasz M. Beer, Oregon Health and Science University, Portland, OR · Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX · Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA · Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC · Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit · and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI · Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA · Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI · Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ · Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA · Oliver Sartor, Tulane School of Medicine, New Orleans, LA · Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School · Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • University of Texas MD Anderson Cancer Center, Houston, TX. · University of Texas MD Anderson Cancer Center, Houston, TX · Pubmed 27432923
  • Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. · Department of Urology and. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 27515962
  • Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Oncology, Alexandra Hospital, University of Athens, Athens, Greece. · Pubmed 27748439
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Adaptive Biotechnologies, Seattle, WA 98102. · Adaptive Biotechnologies, Seattle, WA 98102; Fred Hutchinson Cancer Research Center, Seattle, WA 98102. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 · Pubmed 27698113
  • Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Dan L. Duncan Building (CPB7.3476), 1515 Holcombe Blvd., Unit 1374, Houston, TX, 77030, USA. · Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Dan L. Duncan Building (CPB7.3476), 1515 Holcombe Blvd., Unit 1374, Houston, TX, 77030, USA. · Pubmed 27599544
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Current address: General Internal Medicine Section, Boston Medical Center, Boston University School of Medicine, Boston, MA 02118, USA. · Current address: Infectious Diseases Division, Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI 02903, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 27331874
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: · Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA. · Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH 44195, USA. · Department of Urology, The University of Texas Southwestern Medical School, Dallas, TX 75390, USA. · Department of Urology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA. · Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA. · Moores Cancer Center, University of California, San Diego, San Diego, CA 92093, USA. · Pubmed 27322462
  • The Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 27241286
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC · William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA · Haojin Zhou, Merck, Beijing, China · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France · Catherine M. Tangen, Southwest Oncology Group Statistical Center · Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia · Daniel P. Petrylak, Yale Cancer Center, New Haven, CT · Maha Hussain, University of Michigan, Ann Arbor, MI · Nicholas J. Vogelzang, US Oncology, Las Vegas, NV · Ian M. Thompson, University of Texas at San Antonio, San Antonio · John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX · Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia · Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada · Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom · Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD · Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ · David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles · Eric J. Small, University of California San Francisco, San Francisco, CA · Celestia S. Higano, University of Washington, Seattle, WA · and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
  • Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA. · Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan. · Department of Oncological Sciences, Moffitt Cancer Center, University of South Florida, Tampa, FL, USA. · Department of Integrative Biology and Pharmacology, School of Medicine, School of Biomedical Informatics, UT Health Sciences Center at Houston, Houston, TX, USA. · Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA. · Department of Genitourinary Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA. · Department of Molecular Carcinogenesis, Science Park, UT MD Anderson Cancer Center, Smithville, TX, USA. · Metastasis Research Center, UT MD Anderson Cancer Center, Houston, TX, USA. · Center for Stem Cell and Developmental Biology, UT MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26804168
  • Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Biological Science, College of Natural Sciences, Wonkwang University, Cheonbuk, Iksan, South Korea. · Sanofi Oncology, Cambridge, Massachusetts. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26701088
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Human and Molecular Genetics Program, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Clinical and Translational Sciences Graduate Program, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas. · Pubmed 26546618
  • Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. Programs in Cancer Biology and Cancer Metastasis, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. · Programs in Cancer Biology and Cancer Metastasis, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Imaging Physics-Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. Programs in Cancer Biology and Cancer Metastasis, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. · Pubmed 26272062
  • Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26059275
  • The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. · Pubmed 25714186
2015
  • Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. · Department of Urology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. · Department of Biostatistics, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. · Department of Pathology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. · Pubmed 26171883
  • David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Veterinary Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Alvos Therapeutics, Arrowhead Research Corporation, Pasadena, California. · Pubmed 25832466
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY · Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles · Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA · Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom · Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France · Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia · Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA · Celestia S. Higano, University of Washington, Seattle, WA · Jinhui Li, Janssen Research & Development, Raritan, NJ · and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada. · Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. · Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium. · VU University Medical Center, Amsterdam, the Netherlands. · Janssen Research and Development, Spring House, Pennsylvania. · Janssen Research and Development, Menlo Park, California. · Janssen Research and Development, Los Angeles, California. · Janssen Research and Development, San Diego, California. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Pubmed 25593303
  • Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Department of Urology, Roswell Park Cancer Institute, Buffalo, NY, USA. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. Electronic address: · Pubmed 24882673
  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. Department of Pathology, Taipei Medical University Hospital, Taipei, Taiwan. · Department of Genetics, Center for Cancer Genetics and Genomics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Orthopedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Medicine, Baylor College of Medicine, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26530902
  • Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. · Pubmed 26515605
  • David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; University of New Mexico Cancer Center, University of New Mexico School of Medicine, Albuquerque, NM 87131; Division of Molecular Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; International Research Center, A.C. Camargo Cancer Center, São Paulo, SP 01508-010 Brazil; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · Candiolo Cancer Institute and Department of Oncology, University of Turin, Candiolo 10060, Italy; · University of New Mexico Cancer Center, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Division of Hematology/Oncology, University of New Mexico School of Medicine, Albuquerque, NM 87131; · Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · International Research Center, A.C. Camargo Cancer Center, São Paulo, SP 01508-010 Brazil; · Human Genetics Foundation, Torino 10126, Italy; · Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030; · Harvard Medical School and Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA 02215; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Center for RNA Interference and Noncoding RNA, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · Ludwig Institute for Cancer Research, University of California-San Diego, La Jolla, CA 92093; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; International Research Center, A.C. Camargo Cancer Center, São Paulo, SP 01508-010 Brazil; Institute of Psychiatry, University of São Paulo Medical School, São Paulo 01060, Brazil · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; University of New Mexico Cancer Center, University of New Mexico School of Medicine, Albuquerque, NM 87131; Division of Molecular Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; University of New Mexico Cancer Center, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Division of Hematology/Oncology, University of New Mexico School of Medicine, Albuquerque, NM 87131; · Pubmed 26080435
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • David H. Koch Center, Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030; · University of New Mexico Cancer Center and Divisions of Molecular Medicine and. · Harvard Medical School and Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA 02215 · University of New Mexico Cancer Center and Divisions of Molecular Medicine and · University of New Mexico Cancer Center and Hematology and Oncology, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; and · Pubmed 25762070
  • From the Departments of ‡Translational Molecular Pathology. · ‖Department of Chemistry, Josip Juraj Strossmayer University, 31000 Osijek, Croatia; · ****Department of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia; · ‡‡Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, RI 02903. · §Genitourinary Medical Oncology, University of Texas, M.D. Anderson Cancer Center, Houston, TX; · ¶Department of Medicine, Baylor College of Medicine, Houston, Texas 77030; · From the Departments of ‡Translational Molecular Pathology, · Pubmed 25527621
2014
  • Mary-Ellen Taplin, Massimo Loda, Rosina T. Lis, Wanling Xie, Zhenyang Jiang, and Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School · Glenn J. Bubley, Huihui Ye, and Steven P. Balk, Beth Israel Deaconess Medical Center · Jerome P. Richie, Massimo Loda, and Rosina T. Lis, Brigham and Women's Hospital, Boston, MA · Bruce Montgomery, Bruce L. Dalkin, Lawrence D. True, and Alvin M. Matsumoto, University of Washington · Brett T. Marck and Alvin M. Matsumoto, Geriatric Research, Education and Clinical Center, Veterans' Affairs Puget Sound Health Care System · Elahe A. Mostaghel and Peter S. Nelson, Fred Hutchinson Cancer Research Center, Seattle, WA · Christopher J. Logothetis, John W. Davis, and Patricia Troncoso, University of Texas MD Anderson Cancer Center, Houston, TX · Martin G. Sanda, Emory University School of Medicine, Atlanta, GA · Massimo Loda, King's College London, London, United Kingdom · Trevor M. Penning and Daniel Tamae, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA · and Christopher M. Haqq, NamPhuong Tran, Weimin Peng, Thian Kheoh, and Arturo Molina, Janssen Research and Development, Los Angeles, CA. · Pubmed 25311217
  • Matthew R. Smith, Massachusettes General Hospital · Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA · Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX · Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY · David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI · Daniel J. George, Duke University Medical Center, Durham · Ethan M. Basch, University of North Carolina, Chapel Hill, NC · Celestia S. Higano, University of Washington, Seattle, WA · Andrea L. Harzstark, University of California San Francisco, San Francisco · Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA · A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA · Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV · Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ · Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA · Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 25225437
  • Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA. Electronic address: · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Institut Gustave Roussy, Villejuif, France. · VU University Medical Centre, Amsterdam, Netherlands. · Vienna General Hospital, Medical University Vienna, Vienna, Austria. · Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France. · Centro Médico Austral, Buenos Aires, Argentina. · Centre Jean Perrin, Clermont-Ferrand, France. · St John of God Hospital, Subiaco, WA, Australia. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Hospital de Caridade de Ijuí, Ijuí, Brazil. · Nottingham University Hospital, Nottingham, UK. · Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania. · Hospital Británico de Buenos Aires, Buenos Aires, Argentina. · Herlev Hospital, Herlev, Denmark. · Odense University Hospital, Odense, Denmark. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Bristol-Myers Squibb, Wallingford, CT, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands. · Pubmed 24831977
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25274378
  • Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA. · Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. The Rolanette and Berdon Lawrence Bone Disease Program of Texas, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. University of Athens Greece School of Medicine, Athens 11528, Greece. · Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biological Chemistry, University of Buenos Aires-National Research Council of Argentina (CONICET-IQUIBICEN), Ciudad Autonoma de Buenos Aires C1428EGA, Argentina. · Center for Cancer and Stem Cell Biology, IBT-Texas A&M Health Science Center, Houston, TX 77030, USA. · Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 25186177
  • From the Departments of Genitourinary Medical Oncology, Radiation Oncology, Urology, and Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 24994920
  • University of Texas, M D Anderson Cancer Center, Genitourinary Medical Oncology, Holcombe Blvd, Houston, TX 77030, USA. Electronic address: · Pubmed 24836275
2013
  • Departments of 1Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23811619
  • Industrial Center, Shenzhen Polytechnic, Shenzhen, Guangdong 518055, China ; Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. · Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. · School of Computer Science and Technology, Soochow University, Suzhou 215006, China. · School of Applied Chemistry and Biotechnology, Shenzhen Polytechnic, Shenzhen, Guangdong 518055, China. · Pubmed 24367394
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 23707438
2012
  • University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23142059
  • University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22093188
2011
  • Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA. · Pubmed 21592278
  • Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas. · Department of Bioinformatics and Computational Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas. · Pubmed 21456067
2015
  • Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25155428
2014
  • Authors' Affiliations: Division of Hematology and Medical Oncology; Institute for Precision Medicine, New York Presbyterian; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; Department of Oncology, Memorial Sloan Kettering, New York, New York; Department of Pathology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, The University of Texas MD Anderson Cancer Center; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; Prostate Cancer Foundation, Santa Monica, California; Department of Pathology, University of Washington, Seattle, Washington; and Vancouver Prostate Centre, Vancouver, British Columbia, CanadaAuthors' Affiliations: Division of Hematology and Medical Oncology; Institute for Precision Medicine, New York Presbyterian; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; Department of Oncology, Memorial Sloan Kettering, New York, New York; Department of Pathology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, The University of Texas MD Anderson Cancer Center; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; Prostate Cancer Foundation, Santa Monica, California; Department of Pathology, University of Washington, Seattle, Washington; and Vancouver Prostate Centre, Vancouver, British Columbia, Canada · Authors' Affiliations: Division of Hematology and Medical Oncology; Institute for Precision Medicine, New York Presbyterian; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; Department of Oncology, Memorial Sloan Kettering, New York, New York; Department of Pathology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, The University of Texas MD Anderson Cancer Center; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; Prostate Cancer Foundation, Santa Monica, California; Department of Pathology, University of Washington, Seattle, Washington; and Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Authors' Affiliations: Division of Hematology and Medical Oncology; Institute for Precision Medicine, New York Presbyterian; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; Department of Oncology, Memorial Sloan Kettering, New York, New York; Department of Pathology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, The University of Texas MD Anderson Cancer Center; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; Prostate Cancer Foundation, Santa Monica, California; Department of Pathology, University of Washington, Seattle, Washington; and Vancouver Prostate Centre, Vancouver, British Columbia, CanadaAuthors' Affiliations: Division of Hematology and Medical Oncology; Institute for Precision Medicine, New York Presbyterian; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; Department of Oncology, Memorial Sloan Kettering, New York, New York; Department of Pathology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, The University of Texas MD Anderson Cancer Center; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; Prostate Cancer Foundation, Santa Monica, California; Department of Pathology, University of Washington, Seattle, Washington; and Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Pubmed 24727321
  • The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 25347368
  • Authors' Affiliations: Michigan Center for Translational Pathology; Departments of Pathology, Radiation Oncology, Internal Medicine, Pharmacology, and Urology; Comprehensive Cancer Center; Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, Michigan; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, Texas; Department of Urology, Institute of Prostate Cancer and LeFrak Center For Robotic Surgery; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York Presbyterian Hospitals, New York, New York; Departments of Cancer Biology, Urology, and Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania; and Centre for Integrative Biology, University of Trento, Trento, Italy. · Pubmed 24473064
2013
  • Department of Genitourinary Medical Onology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Pubmed 24211163
  • Memorial Sloan-Kettering Cancer Center, New York; Weill Cornell Medical College, New York, NY; Knight Cancer Institute, Oregon Health & Science University, Portland, OR; Duke University Medical Center, Durham; Cancer Outcomes Research Program, University of North Carolina, Chapel Hill, NC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore; US Food and Drug Administration, Silver Spring, MD; and University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 23943897
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230-3721, USA. · Pubmed 23649003
  • Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA. · Pubmed 23526299
  • UT MD Anderson Cancer Center, Genitourinary Medical Oncology, Houston, Texas 77030, USA. · Pubmed 23371521
  • Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 23339185
  • Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 23102837
2012
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1374, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 22184395
  • The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21976132
  • Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, 77030-4009, USA. · Pubmed 21821830
  • Department of Genitourinary Medical Oncology and David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 23300537
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 23166609
  • Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Herman Pressler, Houston, TX 77230, USA. · Pubmed 23033003
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-3721, USA. · Pubmed 22809348
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Box 1374, 1155 Pressler Street, Houston, TX 77030-3721, USA. · Pubmed 22805323
  • Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, Houston, TX 77030-3721, USA. · Pubmed 22593245
  • Department of Genitourinary Medical Oncology, The David Koch Center for Applied Research of Genitourinary Cancers, The Stanford Alexander Tissue Derivatives Laboratory, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 22457212
  • Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 22156612
  • Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21681775
2011
  • University of Texas MD Anderson Cancer Center, Department of Genitourinary Medical Oncology, Clinical Research Building (T7.3891), 1515 Holcombe Blvd, Unit 0018-4, Houston, TX 77030, USA. · Pubmed 22035268
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 21917607
  • The University of Texas MD Anderson Cancer Center, 1155 Pressler St, Houston, TX 77030-3721, USA. · Pubmed 21606419
  • Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 22586648
  • Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Pubmed 22194926
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA. · Pubmed 21707705
2010
  • Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20551894
  • Department of Genitourinary Medical Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19581923
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 21044312
  • Department of Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20564322
  • Departments of Molecular Pathology, Genitourinary Medical Oncology, and System Biology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 20484040
  • Department of Genitourinary Medical Oncology, The University of Texas MD, Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 20386565
  • University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19853370
2009
  • Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, 77239-1439, USA. · Pubmed 19414670
  • Department of Systems Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19244175
  • Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 19855158
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 19652704
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 19551858
  • Department of Genitourinary Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19202079
Probable:    University of Athens      
2019
  • Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, 1881 East Road, Unit 1907, Houston, TX, 77054, USA. · Department of Bioengineering, Rice University, Houston, TX, USA. · Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, 1881 East Road, Unit 1907, Houston, TX, 77054, USA. · Pubmed 29748904
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
2013
  • Department of Clinical Therapeutics, University of Athens Medical School, Athens, Greece. · Pubmed 22753310
2010
  • Department of Genitourinary Medical Oncology and David H Koch Center for Applied Research of Genitourinary Cancers, University of Athens, Athens, Greece. · Pubmed 20145177
Probable:    Alexandra Hospital Athens      
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 124 total) written by Christopher J. Logothetis about Prostatic Neoplasms:

  • Systematic Review of Systemic Therapies and Therapeutic Combinations with Local Treatments for High-risk Localized Prostate Cancer. 2019
  • Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In Vivo. 2019
  • Current perspectives on bone metastases in castrate-resistant prostate cancer. 2018
  • Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting. 2018
  • Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. 2018
  • Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. 2018
  • Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate Cancer. 2018
  • Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. 2018
  • Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer. 2017
  • Improved Outcomes in Men with Advanced Prostate Cancer. 2017
Show List of Full Article Records
Google Searches

Learn more about Christopher J. Logothetis using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Texas Houston
University of Athens
Alexandra Hospital Athens
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Texas Houston
2019
  • Department of Urology, University Hospitals Leuven, Leuven, Belgium; Nuclear Medicine & Molecular Imaging, KU Leuven, Leuven, Belgium. Electronic address: · Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA, USA. · Urology Service at the Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Oncology in the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, MD, USA. · The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Urology, Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, Quebec, Canada. · Dana-Farber Cancer Institute, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 30286948
  • Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, 1881 East Road, Unit 1907, Houston, TX, 77054, USA. · Department of Bioengineering, Rice University, Houston, TX, USA. · Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, 1881 East Road, Unit 1907, Houston, TX, 77054, USA. · Pubmed 29748904
2018
  • University of Texas-MD Anderson Cancer Center, Houston, TX, USA. · Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY, USA. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Weston Park Hospital, University of Sheffield, Sheffield, UK. · Pubmed 29380085
  • Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA. Electronic address: · The Institute of Cancer Research, London, UK. · Hematology-Oncology Division, Beth Israel Deaconess Medical Center, Boston, MA, USA. · Department of Surgery & Cancer, Imperial College London, Imperial Centre for Translational & Experimental Medicine (ICTEM), Hammersmith Hospital Campus, London, UK. · Department of Molecular & Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Department of Urologic Sciences, University of British Columbia, The Vancouver Prostate Centre, Vancouver, BC, Canada. · Division of Clinical Studies, The Institute of Cancer Research, London, UK. · Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA, USA. · Department of Urology, University of California Davis, Sacramento, CA, USA. · Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA; Department of Urology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA; Department of Hematology/Medical Oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. · Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan. · McDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, TX, USA. · Department of Medicine, Carbone Cancer Center, University of Wisconsin, Madison, WI, USA. · Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Urologic Surgery, Vanderbilt Prostate Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA. · Department of Medicine, University of Washington and VAPSHCS GRECC, Seattle, WA, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Dame Roma Mitchell Cancer Research Laboratories and Freemasons Foundation Centre for Men's Health, Adelaide Medical School, The University of Adelaide, SA, Australia. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA. · Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA; Department of Urology, University of Minnesota, Minneapolis, MN, USA. Electronic address: · Department of Urology, UT Southwestern Medical Center at Dallas, Dallas, TX, USA; Department of Urology and Pharmacology, UT Southwestern Medical Center at Dallas, Dallas, TX, USA. Electronic address: · Pubmed 29258679
  • The Institute of Cancer Research, London, SW7 3RP, UK. · MRC Biostatistics Unit, University of Cambridge, Robinson Way, Cambridge, CB2 0SR, UK. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Cambridge, CB1 8RN, UK. · Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0QQ, UK. · Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, 44106-7219, USA. · Seidman Cancer Center, University Hospitals, Cleveland, OH, 44106, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, 20892, USA. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, 90015, USA. · Institute of Population Health, University of Manchester, Manchester, M13 9PL, UK. · Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK. · Epidemiology Research Program, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA. · SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA. · CHRISTUS Santa Rosa Hospital - Medical Center, San Antonio, TX, 78229, USA. · Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology, Brisbane, QLD, 4059, Australia. · Translational Research Institute, Brisbane, QLD, 4102, Australia. · Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, 4222, Australia. · Cancer Council Queensland, Fortitude Valley, QLD, 4006, Australia. · Chris O'Brien Lifehouse (COBLH), Camperdown, Sydney, NSW, 2010, Australia. · Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia. · Dame Roma Mitchell Cancer Research Centre, University of Adelaide, Adelaide, SA, 5005, Australia. · Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia. · Prostate Cancer Translational Research Program, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Department of Medical Epidemiology and Biostatistics, Karolinska Institute, SE-171 77, Stockholm, Sweden. · Department of Molecular Medicine and Surgery, Karolinska Institutet, and Department of Urology, Karolinska University Hospital, 171 76, Stockholm, Sweden. · Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, 182 88, Stockholm, Sweden. · Centre for Cancer Genetic Epidemiology, Department of Oncology, Strangeways Laboratory, University of Cambridge, Cambridge, CB1 8RN, UK. · Department of Applied Health Research, University College London, London, WC1E 7HB, UK. · Institute of Biomedicine, University of Turku, FI-20014, Turku, Finland. · Tyks Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, 20521, Turku, Finland. · Department of Urology, Tampere University Hospital, University of Tampere, Kalevantie 4, FI-33014, Tampere, Finland. · Department of Epidemiology, School of Health Sciences, University of Tampere, FI-33014, Tampere, Finland. · Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, SE-171 77, Stockholm, Sweden. · Division of Cancer Sciences, Manchester Academic Health Science Centre, Radiotherapy Related Research, Manchester NIHR Biomedical Research Centre, The Christie Hospital NHS Foundation Trust, University of Manchester, Manchester, M13 9PL, UK. · University of Cambridge Department of Oncology, Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB1 8RN, UK. · Department of Epidemiology, Harvard School of Public Health, Boston, MA, 02115, USA. · Washington University School of Medicine, St. Louis, MO, 63110, USA. · GRC N°5 ONCOTYPE-URO, UPMC Univ Paris 06, Tenon Hospital, F-75020, Paris, France. · CeRePP, Tenon Hospital, F-75020, Paris, France. · Department of Molecular Medicine, Aarhus University Hospital, 8200, Aarhus N, Denmark. · Department of Clinical Medicine, Aarhus University, 8200, Aarhus N, Denmark. · Department of Urology, Aarhus University Hospital, 8200, Aarhus N, Denmark. · Department of Medical Genetics, Oslo University Hospital, 0424, Oslo, Norway. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0QQ, UK. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, CB2 0RE, UK. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, OX1 2JD, UK. · School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. · Faculty of Medical Science, John Radcliffe Hospital, University of Oxford, Oxford, OX1 2JD, UK. · Medical Research Council (MRC) Integrative Epidemiology Unit, University of Bristol, Bristol, BS8 2BN, UK. · National Institute for Health Research (NIHR) Biomedical Research Centre, University of Bristol, Bristol, BS8 1TH, UK. · Cancer Epidemiology, Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK. · Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, ON, M5G 2M9, Canada. · Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. · Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029-5674, USA. · Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, 14620, USA. · Professor of Pathology and Pediatrics, Albert Einstein College of Medicine, Bronx, NY, 10461, USA. · Centre for Molecular Oncology, Barts Cancer Institute, John Vane Science Centre, Queen Mary University of London, London, EC1M 6BQ, UK. · Second Military Medical University, Shanghai, 200433, P. R. China. · Wuxi Second Hospital, Nanjing Medical University, Wuxi, Jiangzhu, 214003, China. · Department of Urology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, 200032, China. · The People's Hospital of Liaoning Province and The People's Hospital of China Medical University, Shenyang, 110001, China. · Department of Urology, Zhongshan Hospital, Fudan University Medical College, Shanghai, 200032, China. · Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, VIC, 3004, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, 3010, Australia. · Precision Medicine, School and Clinical Sciences at Monash Health, Monash University, Clayton, VIC, 3168, Australia. · Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia. · Division of Urologic Surgery, Brigham and Womens Hospital, Boston, MA, 02115, USA. · Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica, CIBERER, IDIS, Santiago de Compostela, 15706, Spain. · Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, 15706, Santiago de Compostela, Spain. · Division of Family Medicine, Department of Neurobiology, Care Science and Society, Karolinska Institutet, Huddinge, SE-171 77, Stockholm, Sweden. · Scandinavian Development Services, 182 33, Danderyd, Sweden. · Centre for Research in Environmental Epidemiology (CREAL), Barcelona Institute for Global Health (ISGlobal), 08003, Barcelona, Spain. · CIBER Epidemiología y Salud Pública (CIBERESP), 28029, Madrid, Spain. · IMIM (Hospital del Mar Research Institute), 08003, Barcelona, Spain. · Universitat Pompeu Fabra (UPF), 08002, Barcelona, Spain. · University of Cantabria-IDIVAL, 39005, Santander, Spain. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, 02184, USA. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, 33612, USA. · School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA. · Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109-1024, USA. · Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, 98195, USA. · International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 70-115, Szczecin, Poland. · National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 20892, USA. · Faculty of Health and Medical Sciences, University of Copenhagen, 2200, Copenhagen, Denmark. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2200, Copenhagen, Denmark. · Department of Urology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2200, Copenhagen, Denmark. · Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, Copenhagen University Hospital, DK-2730, Herlev, Denmark. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), D-69120, Heidelberg, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), D-69120, Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120, Heidelberg, Germany. · Saarland Cancer Registry, 66119, Saarbrücken, Germany. · Institute for Human Genetics, University Hospital Ulm, 89075, Ulm, Germany. · Department of Urology, University Hospital Ulm, 89075, Ulm, Germany. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Cancer Prevention Institute of California, Fremont, CA, 94538, USA. · Department of Health Research & Policy (Epidemiology) and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305-5101, USA. · Department of Genetics, Portuguese Oncology Institute of Porto, 4200-072, Porto, Portugal. · Biomedical Sciences Institute (ICBAS), University of Porto, 4050-313, Porto, Portugal. · Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, 91010, USA. · Ghent University, Faculty of Medicine and Health Sciences, Basic Medical Sciences, B-9000, Gent, Belgium. · Department of Radiotherapy, Ghent University Hospital, B-9000, Gent, Belgium. · Department of Surgery, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia. · Cancer Research Malaysia (CRM), Outpatient Centre, Subang Jaya Medical Centre, 47500, Subang Jaya, Selangor, Malaysia. · Department of Urology, University of Washington, Seattle, WA, 98195, USA. · Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, D-20246, Hamburg, Germany. · Division of Medical Oncology, Urogenital Unit, Department of Oncology at the University Hospital Centre Zagreb, Šalata 2, 10000, Zagreb, Croatia. · Department of Urology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Šalata 2, 10000, Zagreb, Croatia. · Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, 1431, Sofia, Bulgaria. · Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, T6G 1Z2, Canada. · Division of Radiation Oncology, Cross Cancer Institute, Edmonton, AB, T6G 1Z2, Canada. · Department of Urology and Alexandrovska University Hospital, Medical University of Sofia, 1431, Sofia, Bulgaria. · Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, BE-3000, Leuven, Belgium. · Department of Urology, University Hospitals Leuven, BE-3000, Leuven, Belgium. · Southampton General Hospital, The University of Southampton, Southampton, SO16 6YD, UK. · Manchester Cancer Research Centre, Faculty of Biology Medicine & Health, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Health Innovation Manchester, University of Manchester, Manchester, M13 9WL, UK. · The University of Surrey, Guildford, Surrey, GU2 7XH, UK. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saúde, SERGAS, 15706, Santiago de Compostela, Spain. · Moores Cancer Center, University of California San Diego, La Jolla, CA, 92037, USA. · Genetic Oncology Unit, CHUVI Hospital, Complexo Hospitalario Universitario de Vigo, Instituto de Investigación Biomédica Galicia Sur (IISGS), 36204, Vigo (Pontevedra), Spain. · Moores Cancer Center, Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA, 92093-0012, USA. · Department of Urology, Erasmus University Medical Center, 3015 CE, Rotterdam, The Netherlands. · Department of Clinical Chemistry, Erasmus University Medical Center, 3015 CE, Rotterdam, The Netherlands. · Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, 94807, Villejuif Cédex, France. · Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, 60201, USA. · Clinical Gerontology Unit, University of Cambridge, Cambridge, CB2 2QQ, UK. · Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, 84112, USA. · George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, 84148, USA. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA. · Division of Biomedical Statistics & Informatics, Mayo Clinic, Rochester, MN, 55905, USA. · Department of Epidemiology, University of Washington, Seattle, WA, 98195, USA. · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA. · Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, SW7 2AZ, UK. · Genomics England, Queen Mary University of London, Dawson Hall, Charterhouse Square, London, EC1M 6BQ, UK. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), D-69120, Heidelberg, Germany. · Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA. · Dana-Farber Cancer Institute, Boston, MA, 02215, USA. · Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK. · The Institute of Cancer Research, London, SW7 3RP, UK. · Pubmed 29892050
  • Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA. · Seidman Cancer Center, University Hospitals, Cleveland, OH, USA. · Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK. · Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA. · Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK. · Institute of Cancer Research, London, UK. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA. · Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica, CIBERER, IDIS, Santiago de Compostela, Spain. · Department of Oncology, Centre for Cancer Genetic Epidemiology, Strangeways Laboratory, University of Cambridge, Cambridge, UK. · Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK. · Warwick Medical School, University of Warwick, Coventry, UK. · Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA. · SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · CHRISTUS Santa Rosa Hospital-Medical Center, San Antonio, TX, USA. · Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia. · Australian Prostate Cancer Research Centre-Qld, Translational Research Institute, Brisbane, Queensland, Australia. · Menzies Health Institute of Queensland, Griffith University, Nathan, Queensland, Australia. · Cancer Council Queensland, Fortitude Valley, Queensland, Australia. · Chris O'Brien Lifehouse (COBLH), Camperdown, New South Wales, Australia. · Garvan Institute of Medical Research, Sydney, New South Wales, Australia. · Dame Roma Mitchell Cancer Research Centre, University of Adelaide, Adelaide, South Australia, Australia. · Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Program, Department of Anatomy and Developmental Biology, Monash University, Victoria, Australia. · Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Department of Urology, Karolinska University Hospital, Stockholm, Sweden. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. · Department of Clinical Sciences at Danderyds Hospital, Karolinska Institutet, Stockholm, Sweden. · Department of Applied Health Research, University College London, London, UK. · Institute of Biomedicine, University of Turku, Turku, Finland. · Tyks Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, Turku, Finland. · Department of Urology, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. · Department of Epidemiology, School of Health Sciences, University of Tampere, Tampere, Finland. · Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. · Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. · Division of Cancer Sciences, Manchester Cancer Research Centre, Manchester Academic Health Science Centre and Christie NHS Foundation Trust, University of Manchester, Manchester, UK. · Department of Oncology, Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge, UK. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Washington University School of Medicine, St. Louis, MO, USA. · UPMC Sorbonne Universités, GRC no. 5 ONCOTYPE-URO, Tenon Hospital, Paris, France. · CeRePP, Tenon Hospital, Paris, France. · Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark. · Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. · Department of Urology, Aarhus University Hospital, Aarhus, Denmark. · Department of Medical Genetics, Oslo University Hospital, Oslo, Norway. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK. · Cancer Research UK, Cambridge Research Institute, Cambridge, UK. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK, Faculty of Medical Science, John Radcliffe Hospital, University of Oxford, Oxford, UK. · School of Social and Community Medicine, University of Bristol, Bristol, UK. · Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. · Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Division of Urology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA. · Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA. · Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. · Second Military Medical University, Shanghai, China. · Wuxi Second Hospital, Nanjing Medical University, Wuxi, China. · Department of Urology, First Affiliated Hospital, Chongqing Medical University, Chongqing, China. · Department of Urology, Zhongshan Hospital, Fudan University Medical College, Shanghai, China. · People's Hospital of Liaoning Province, People's Hospital of China Medical University, Shenyang, China. · Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia. · Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia. · Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia. · Division of Urologic Surgery, Brigham and Womens Hospital, Boston, MA, USA. · Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain. · Division of Family Medicine, Department of Neurobiology, Care Science and Society, Karolinska, Institutet, Huddinge, Sweden. · Scandinavian Development Services, Danderyd, Sweden. · ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain. · CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. · IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Universitat Pompeu Fabra (UPF), Barcelona, Spain. · University of Cantabria-IDIVAL, Santander, Spain. · Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA. · Biostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, USA. · Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA. · International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Urology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · Saarland Cancer Registry, Saarbrücken, Germany. · Institute for Human Genetics, University Hospital Ulm, Ulm, Germany. · Department of Urology, University Hospital Ulm, Ulm, Germany. · Department of Genitourinary Medical Oncology, University of Texas-MD Anderson Cancer Center, Houston, TX, USA. · Cancer Prevention Institute of California, Fremont, CA, USA. · Department of Health Research & Policy (Epidemiology) and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. · Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal. · Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal. · Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, USA. · Faculty of Medicine and Health Sciences, Basic Medical Sciences, Ghent University, Ghent, Belgium. · Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium. · Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. · Cancer Research Malaysia (CRM), Outpatient Centre, Subang Jaya Medical Centre, Selangor, Malaysia. · Department of Urology, University of Washington, Seattle, WA, USA. · Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Oncology, Division of Medical Oncology, Urogenital Unit, University Hospital Centre Zagreb, Zagreb, Croatia. · Department of Urology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia. · Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, Sofia, Bulgaria. · Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada. · Division of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada. · Department of Urology and Alexandrovska University Hospital, Medical University of Sofia, Sofia, Bulgaria. · Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. · Department of Urology, University Hospitals Leuven, Leuven, Belgium. · University of Southampton, Southampton General Hospital, Southampton, UK. · Division of Cancer Sciences, Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Center, NIHR Manchester Biomedical Research Centre, Health Innovation Manchester, University of Manchester, Manchester, UK. · University of Surrey, Guildford, Surrey, UK. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saúde, SERGAS, Santiago de Compostela, Spain. · Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. · Genetic Oncology Unit, CHUVI Hospital, Instituto de Investigación Biomédica Galicia Sur (IISGS), Complexo Hospitalario Universitario de Vigo, Vigo, Spain. · Department of Family Medicine and Public Health, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. · Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands. · Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France. · Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA. · Clinical Gerontology Unit, University of Cambridge, Cambridge, UK. · Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA. · George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, USA. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA. · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. · Genomics England, Queen Mary University of London, London, UK. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA. · Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA. · Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. · Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA. · Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. · Institute of Cancer Research, London, UK. · Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 29892016
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai, China. · Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. · Michigan Center for Translational Pathology, Howard Hughes Medical Institute, Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 29138344
  • Department of Medical Oncology, Cantonal Hospital St. Gallen and University of Berne, Switzerland. Electronic address: · Department of Medical Oncology, The Institute of Cancer Research/Royal Marsden, London, UK. · Oregon Health & Science University Knight Cancer Institute, OR, USA. · Department of Medical Oncology, Weill Cornell Medicine, New York, NY, USA. · Department of Radiation Oncology, Genito Urinary Oncology, Prostate Brachytherapy Unit, Goustave Roussy, Paris, France. · Department of Radiation Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, USA. · Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, NY, USA. · Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. · Department of Urology, Gangnam Severance Hospital, Yonsei University Health System, Seoul, Korea. · Department of Urology, The Christie and Salford Royal Hospitals, Manchester, UK. · Department of Medical Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Department of Urology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil. · Department of Medical Oncology, Division of Haematology/Oncology, Columbia University Medical Center, New York, NY, USA. · Department of Clinical Oncology and Genetics, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · Department of Medical Oncology, University of Texas MD Anderson Cancer Center, TX, USA. · Department of Urology, University of California, Davis School of Medicine, CA, USA. · Department of Nuclear Medicine, Policlinico S. Orsola, Università di Bologna, Italy. · Department of Radiation Oncology, University of California, San Francisco, CA, USA. · Department of Medical Oncology, Gustave Roussy, University of Paris Sud, Paris, France. · Department of Surgery, Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and Health Sciences, Monash University. · Department of Urology, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. · Department of Clinical trials and Statistics, Duke University, Durham, NC, USA. · Department of Urology, University Hospital Köln, Köln, Germany. · Department of Medicine, Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, WA, USA. · Department of Clinical Oncology, Clinical Oncology Queen Elizabeth Hospital Birmingham and University of Birmingham, Birmingham, UK. · Department of Medical Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Clinical Oncology, Tampere University Hospital, Faculty of Medicine and Life Sciences, University of Tampere, Finland. · Department of Urology, American University of Beirut Medical Center, Beirut, Lebanon. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston, TX, USA. · Department of Medical Oncology Hospital Israelita Albert Einstein and Department of Medical Oncology Beneficência Portuguesa de São Paulo. · Department of Medical Oncology and Epidemiology, Vanderbilt University Medical Center, Division of Hematology/Oncology, Nashville, TN, USA. · Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Urology, University Hospital Nord St. Etienne, St. Etienne, France. · Department of Radiation Oncology, Tata Memorial Centre, Mumbai, India. · Department of Medical Oncology, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA. · Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium. · Department of Radiology, Mount Vernon Cancer Centre and Institute of Cancer Research, London, UK. · Department of Clinical Oncology, Royal Marsden NHS Foundation Trust, Sutton, UK. · Department of Pathology, University of Washington, WA, USA. · Department of Pathology, University of Bern and the Inselspital, Bern (CH). · Department of Medical Oncology, Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of, California, San Francisco, CA, USA. · Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Department of Medical Oncology, Tulane Cancer Center, New Orleans, LA, USA. · Department of Medical Oncology, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Centre, New York, NY, USA. · Department of Medical Oncology, Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Department of Medical Oncology, Massachusetts General Hospital Cancer Centre, Boston, MA, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. · Department of Medical Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada. · Department of Urology, Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Oncology and Haemato-oncology, Università degli Studi di Milano. Radiation Oncology 1, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Radiation Oncology, Klinik für Strahlentherapie und Radioonkologie des Universitätsklinikum Ulm, Albert-Einstein-Allee, Ulm, Germany. · Department of Medical Oncology, Cantonal Hospital St. Gallen and University of Berne, Switzerland. · Pubmed 28655541
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
  • From the University of Texas M.D. Anderson Cancer Center, Houston. · Pubmed 28745978
  • Tomasz M. Beer, Oregon Health and Science University, Portland, OR · Eugene D. Kwon, Mayo Clinic, Rochester, MN · Charles G. Drake, Johns Hopkins University, Baltimore, MD · Karim Fizazi, University of Paris-Sud, Villejuif · Gwenaelle Gravis, Institut Paoli-Calmettes, Marseille, France · Christopher Logothetis, University of Texas MD Anderson Cancer Center, Houston, TX · Vinod Ganju, Monash University, Melbourne, Victoria · Siobhan S. Ng, St John of God Hospital, Subiaco, Western Australia · Francis X. Parnis, Adelaide Cancer Centre, Adelaide, South Australia, Australia · Jonathan Polikoff, Southern California Permanente Medical Group, San Marcos, CA · Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada · Piotr Humanski, Niepubliczny Zaklad Opieki Zdrowotnej Specjalista, Kutno, Poland · Josep M. Piulats, Institut Català d'Oncologia, Barcelona · Javier Puente, Hospital Clínico San Carlos, Madrid, Spain · Pablo Gonzalez Mella, Instituto Oncologico, Viña del Mar · Pablo Gonzalez Mella, Fundación Arturo Lopez Pérez, Santiago, Chile · Dirk Jaeger, University Hospital, Heidelberg, Germany · Fabio A. Franke, Hospital de Caridade de Ijuí, Ijuí, Brazil · Roman Carvajal, Hospital Regional Valentin Gomez Farias, Zapopan, Mexico · Lisa Sengeløv, Herlev Hospital, Herlev, Denmark · M. Brent McHenry, Bristol-Myers Squibb, Wallingford, CT · Arvind Varma, DOCS Inc, New York, NY · Alfonsus J. van den Eertwegh, VU University Medical Center, Amsterdam · and Winald Gerritsen, Radboud University, Nijmegen, the Netherlands. · Pubmed 28034081
  • Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, 1365 Clifton Road NE, B4301, Atlanta, GA, 30322, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030-3721, USA. · Pubmed 28730293
  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, Taipei Medical University and Hospital, Taipei 110, Taiwan. · Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Medicine, McGill University, Montreal, QC, H3A 1G1, Canada. · Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: · Pubmed 28586644
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · ORBIT (Oncology Research for Biologics and Immunotherapy Translation), The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. · Pubmed 28536297
  • Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · The Immunotherapy Platform, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Janssen Oncology Therapeutic Area, Janssen Research and Development, LLC, Pharmaceutical Companies of Johnson &Johnson, Spring House, Pennsylvania, USA. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 28346412
  • Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, California. · Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, California. · Viterbi School of Engineering, University of Southern California, Los Angeles, California. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27702818
  • Ana Aparicio and Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX. · Pubmed 27937088
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College · David Nanus, NewYork Presbyterian Weill Cornell Medical Center · Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY · Walter M. Stadler, University of Chicago Medicine, Chicago, IL · Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA · Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC · Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD · Tomasz M. Beer, Oregon Health and Science University, Portland, OR · Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX · Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA · Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC · Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit · and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI · Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA · Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI · Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ · Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA · Oliver Sartor, Tulane School of Medicine, New Orleans, LA · Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School · Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • University of Texas MD Anderson Cancer Center, Houston, TX. · University of Texas MD Anderson Cancer Center, Houston, TX · Pubmed 27432923
  • Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. · Department of Urology and. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 27515962
  • Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Oncology, Alexandra Hospital, University of Athens, Athens, Greece. · Pubmed 27748439
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Adaptive Biotechnologies, Seattle, WA 98102. · Adaptive Biotechnologies, Seattle, WA 98102; Fred Hutchinson Cancer Research Center, Seattle, WA 98102. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 · Pubmed 27698113
  • Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Dan L. Duncan Building (CPB7.3476), 1515 Holcombe Blvd., Unit 1374, Houston, TX, 77030, USA. · Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Dan L. Duncan Building (CPB7.3476), 1515 Holcombe Blvd., Unit 1374, Houston, TX, 77030, USA. · Pubmed 27599544
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Current address: General Internal Medicine Section, Boston Medical Center, Boston University School of Medicine, Boston, MA 02118, USA. · Current address: Infectious Diseases Division, Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI 02903, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 27331874
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: · Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA. · Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH 44195, USA. · Department of Urology, The University of Texas Southwestern Medical School, Dallas, TX 75390, USA. · Department of Urology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA. · Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA. · Moores Cancer Center, University of California, San Diego, San Diego, CA 92093, USA. · Pubmed 27322462
  • The Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 27241286
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC · William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA · Haojin Zhou, Merck, Beijing, China · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France · Catherine M. Tangen, Southwest Oncology Group Statistical Center · Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia · Daniel P. Petrylak, Yale Cancer Center, New Haven, CT · Maha Hussain, University of Michigan, Ann Arbor, MI · Nicholas J. Vogelzang, US Oncology, Las Vegas, NV · Ian M. Thompson, University of Texas at San Antonio, San Antonio · John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX · Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia · Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada · Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom · Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD · Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ · David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles · Eric J. Small, University of California San Francisco, San Francisco, CA · Celestia S. Higano, University of Washington, Seattle, WA · and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
  • Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA. · Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan. · Department of Oncological Sciences, Moffitt Cancer Center, University of South Florida, Tampa, FL, USA. · Department of Integrative Biology and Pharmacology, School of Medicine, School of Biomedical Informatics, UT Health Sciences Center at Houston, Houston, TX, USA. · Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA. · Department of Genitourinary Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA. · Department of Molecular Carcinogenesis, Science Park, UT MD Anderson Cancer Center, Smithville, TX, USA. · Metastasis Research Center, UT MD Anderson Cancer Center, Houston, TX, USA. · Center for Stem Cell and Developmental Biology, UT MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26804168
  • Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Biological Science, College of Natural Sciences, Wonkwang University, Cheonbuk, Iksan, South Korea. · Sanofi Oncology, Cambridge, Massachusetts. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26701088
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Human and Molecular Genetics Program, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Clinical and Translational Sciences Graduate Program, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas. · Pubmed 26546618
  • Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. Programs in Cancer Biology and Cancer Metastasis, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. · Programs in Cancer Biology and Cancer Metastasis, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Imaging Physics-Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. Programs in Cancer Biology and Cancer Metastasis, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. · Pubmed 26272062
  • Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26059275
  • The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. · Pubmed 25714186
2015
  • Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. · Department of Urology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. · Department of Biostatistics, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. · Department of Pathology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. · Pubmed 26171883
  • David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Veterinary Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Alvos Therapeutics, Arrowhead Research Corporation, Pasadena, California. · Pubmed 25832466
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY · Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles · Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA · Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom · Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France · Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia · Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA · Celestia S. Higano, University of Washington, Seattle, WA · Jinhui Li, Janssen Research & Development, Raritan, NJ · and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada. · Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. · Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium. · VU University Medical Center, Amsterdam, the Netherlands. · Janssen Research and Development, Spring House, Pennsylvania. · Janssen Research and Development, Menlo Park, California. · Janssen Research and Development, Los Angeles, California. · Janssen Research and Development, San Diego, California. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Pubmed 25593303
  • Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Department of Urology, Roswell Park Cancer Institute, Buffalo, NY, USA. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. Electronic address: · Pubmed 24882673
  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. Department of Pathology, Taipei Medical University Hospital, Taipei, Taiwan. · Department of Genetics, Center for Cancer Genetics and Genomics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Orthopedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Medicine, Baylor College of Medicine, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26530902
  • Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. · Pubmed 26515605
  • David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; University of New Mexico Cancer Center, University of New Mexico School of Medicine, Albuquerque, NM 87131; Division of Molecular Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; International Research Center, A.C. Camargo Cancer Center, São Paulo, SP 01508-010 Brazil; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · Candiolo Cancer Institute and Department of Oncology, University of Turin, Candiolo 10060, Italy; · University of New Mexico Cancer Center, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Division of Hematology/Oncology, University of New Mexico School of Medicine, Albuquerque, NM 87131; · Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · International Research Center, A.C. Camargo Cancer Center, São Paulo, SP 01508-010 Brazil; · Human Genetics Foundation, Torino 10126, Italy; · Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030; · Harvard Medical School and Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA 02215; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Center for RNA Interference and Noncoding RNA, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · Ludwig Institute for Cancer Research, University of California-San Diego, La Jolla, CA 92093; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; International Research Center, A.C. Camargo Cancer Center, São Paulo, SP 01508-010 Brazil; Institute of Psychiatry, University of São Paulo Medical School, São Paulo 01060, Brazil · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; University of New Mexico Cancer Center, University of New Mexico School of Medicine, Albuquerque, NM 87131; Division of Molecular Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; University of New Mexico Cancer Center, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Division of Hematology/Oncology, University of New Mexico School of Medicine, Albuquerque, NM 87131; · Pubmed 26080435
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • David H. Koch Center, Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030; · University of New Mexico Cancer Center and Divisions of Molecular Medicine and. · Harvard Medical School and Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA 02215 · University of New Mexico Cancer Center and Divisions of Molecular Medicine and · University of New Mexico Cancer Center and Hematology and Oncology, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; and · Pubmed 25762070
  • From the Departments of ‡Translational Molecular Pathology. · ‖Department of Chemistry, Josip Juraj Strossmayer University, 31000 Osijek, Croatia; · ****Department of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia; · ‡‡Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, RI 02903. · §Genitourinary Medical Oncology, University of Texas, M.D. Anderson Cancer Center, Houston, TX; · ¶Department of Medicine, Baylor College of Medicine, Houston, Texas 77030; · From the Departments of ‡Translational Molecular Pathology, · Pubmed 25527621
2014
  • Mary-Ellen Taplin, Massimo Loda, Rosina T. Lis, Wanling Xie, Zhenyang Jiang, and Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School · Glenn J. Bubley, Huihui Ye, and Steven P. Balk, Beth Israel Deaconess Medical Center · Jerome P. Richie, Massimo Loda, and Rosina T. Lis, Brigham and Women's Hospital, Boston, MA · Bruce Montgomery, Bruce L. Dalkin, Lawrence D. True, and Alvin M. Matsumoto, University of Washington · Brett T. Marck and Alvin M. Matsumoto, Geriatric Research, Education and Clinical Center, Veterans' Affairs Puget Sound Health Care System · Elahe A. Mostaghel and Peter S. Nelson, Fred Hutchinson Cancer Research Center, Seattle, WA · Christopher J. Logothetis, John W. Davis, and Patricia Troncoso, University of Texas MD Anderson Cancer Center, Houston, TX · Martin G. Sanda, Emory University School of Medicine, Atlanta, GA · Massimo Loda, King's College London, London, United Kingdom · Trevor M. Penning and Daniel Tamae, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA · and Christopher M. Haqq, NamPhuong Tran, Weimin Peng, Thian Kheoh, and Arturo Molina, Janssen Research and Development, Los Angeles, CA. · Pubmed 25311217
  • Matthew R. Smith, Massachusettes General Hospital · Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA · Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX · Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY · David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI · Daniel J. George, Duke University Medical Center, Durham · Ethan M. Basch, University of North Carolina, Chapel Hill, NC · Celestia S. Higano, University of Washington, Seattle, WA · Andrea L. Harzstark, University of California San Francisco, San Francisco · Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA · A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA · Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV · Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ · Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA · Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 25225437
  • Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA. Electronic address: · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Institut Gustave Roussy, Villejuif, France. · VU University Medical Centre, Amsterdam, Netherlands. · Vienna General Hospital, Medical University Vienna, Vienna, Austria. · Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France. · Centro Médico Austral, Buenos Aires, Argentina. · Centre Jean Perrin, Clermont-Ferrand, France. · St John of God Hospital, Subiaco, WA, Australia. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Hospital de Caridade de Ijuí, Ijuí, Brazil. · Nottingham University Hospital, Nottingham, UK. · Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania. · Hospital Británico de Buenos Aires, Buenos Aires, Argentina. · Herlev Hospital, Herlev, Denmark. · Odense University Hospital, Odense, Denmark. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Bristol-Myers Squibb, Wallingford, CT, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands. · Pubmed 24831977
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25274378
  • Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA. · Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. The Rolanette and Berdon Lawrence Bone Disease Program of Texas, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. University of Athens Greece School of Medicine, Athens 11528, Greece. · Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biological Chemistry, University of Buenos Aires-National Research Council of Argentina (CONICET-IQUIBICEN), Ciudad Autonoma de Buenos Aires C1428EGA, Argentina. · Center for Cancer and Stem Cell Biology, IBT-Texas A&M Health Science Center, Houston, TX 77030, USA. · Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 25186177
  • From the Departments of Genitourinary Medical Oncology, Radiation Oncology, Urology, and Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 24994920
  • University of Texas, M D Anderson Cancer Center, Genitourinary Medical Oncology, Holcombe Blvd, Houston, TX 77030, USA. Electronic address: · Pubmed 24836275
2013
  • Departments of 1Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23811619
  • Industrial Center, Shenzhen Polytechnic, Shenzhen, Guangdong 518055, China ; Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. · Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. · School of Computer Science and Technology, Soochow University, Suzhou 215006, China. · School of Applied Chemistry and Biotechnology, Shenzhen Polytechnic, Shenzhen, Guangdong 518055, China. · Pubmed 24367394
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 23707438
2012
  • University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23142059
  • University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22093188
2011
  • Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA. · Pubmed 21592278
  • Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas. · Department of Bioinformatics and Computational Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas. · Pubmed 21456067
2015
  • Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25155428
2014
  • Authors' Affiliations: Division of Hematology and Medical Oncology; Institute for Precision Medicine, New York Presbyterian; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; Department of Oncology, Memorial Sloan Kettering, New York, New York; Department of Pathology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, The University of Texas MD Anderson Cancer Center; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; Prostate Cancer Foundation, Santa Monica, California; Department of Pathology, University of Washington, Seattle, Washington; and Vancouver Prostate Centre, Vancouver, British Columbia, CanadaAuthors' Affiliations: Division of Hematology and Medical Oncology; Institute for Precision Medicine, New York Presbyterian; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; Department of Oncology, Memorial Sloan Kettering, New York, New York; Department of Pathology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, The University of Texas MD Anderson Cancer Center; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; Prostate Cancer Foundation, Santa Monica, California; Department of Pathology, University of Washington, Seattle, Washington; and Vancouver Prostate Centre, Vancouver, British Columbia, Canada · Authors' Affiliations: Division of Hematology and Medical Oncology; Institute for Precision Medicine, New York Presbyterian; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; Department of Oncology, Memorial Sloan Kettering, New York, New York; Department of Pathology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, The University of Texas MD Anderson Cancer Center; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; Prostate Cancer Foundation, Santa Monica, California; Department of Pathology, University of Washington, Seattle, Washington; and Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Authors' Affiliations: Division of Hematology and Medical Oncology; Institute for Precision Medicine, New York Presbyterian; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; Department of Oncology, Memorial Sloan Kettering, New York, New York; Department of Pathology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, The University of Texas MD Anderson Cancer Center; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; Prostate Cancer Foundation, Santa Monica, California; Department of Pathology, University of Washington, Seattle, Washington; and Vancouver Prostate Centre, Vancouver, British Columbia, CanadaAuthors' Affiliations: Division of Hematology and Medical Oncology; Institute for Precision Medicine, New York Presbyterian; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; Department of Oncology, Memorial Sloan Kettering, New York, New York; Department of Pathology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, The University of Texas MD Anderson Cancer Center; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; Prostate Cancer Foundation, Santa Monica, California; Department of Pathology, University of Washington, Seattle, Washington; and Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Pubmed 24727321
  • The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 25347368
  • Authors' Affiliations: Michigan Center for Translational Pathology; Departments of Pathology, Radiation Oncology, Internal Medicine, Pharmacology, and Urology; Comprehensive Cancer Center; Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, Michigan; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, Texas; Department of Urology, Institute of Prostate Cancer and LeFrak Center For Robotic Surgery; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York Presbyterian Hospitals, New York, New York; Departments of Cancer Biology, Urology, and Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania; and Centre for Integrative Biology, University of Trento, Trento, Italy. · Pubmed 24473064
2013
  • Department of Genitourinary Medical Onology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Pubmed 24211163
  • Memorial Sloan-Kettering Cancer Center, New York; Weill Cornell Medical College, New York, NY; Knight Cancer Institute, Oregon Health & Science University, Portland, OR; Duke University Medical Center, Durham; Cancer Outcomes Research Program, University of North Carolina, Chapel Hill, NC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore; US Food and Drug Administration, Silver Spring, MD; and University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 23943897
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230-3721, USA. · Pubmed 23649003
  • Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA. · Pubmed 23526299
  • UT MD Anderson Cancer Center, Genitourinary Medical Oncology, Houston, Texas 77030, USA. · Pubmed 23371521
  • Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 23339185
  • Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 23102837
2012
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1374, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 22184395
  • The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21976132
  • Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, 77030-4009, USA. · Pubmed 21821830
  • Department of Genitourinary Medical Oncology and David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 23300537
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 23166609
  • Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Herman Pressler, Houston, TX 77230, USA. · Pubmed 23033003
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-3721, USA. · Pubmed 22809348
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Box 1374, 1155 Pressler Street, Houston, TX 77030-3721, USA. · Pubmed 22805323
  • Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, Houston, TX 77030-3721, USA. · Pubmed 22593245
  • Department of Genitourinary Medical Oncology, The David Koch Center for Applied Research of Genitourinary Cancers, The Stanford Alexander Tissue Derivatives Laboratory, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 22457212
  • Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 22156612
  • Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21681775
2011
  • University of Texas MD Anderson Cancer Center, Department of Genitourinary Medical Oncology, Clinical Research Building (T7.3891), 1515 Holcombe Blvd, Unit 0018-4, Houston, TX 77030, USA. · Pubmed 22035268
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 21917607
  • The University of Texas MD Anderson Cancer Center, 1155 Pressler St, Houston, TX 77030-3721, USA. · Pubmed 21606419
  • Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 22586648
  • Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Pubmed 22194926
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA. · Pubmed 21707705
2010
  • Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20551894
  • Department of Genitourinary Medical Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19581923
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 21044312
  • Department of Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20564322
  • Departments of Molecular Pathology, Genitourinary Medical Oncology, and System Biology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 20484040
  • Department of Genitourinary Medical Oncology, The University of Texas MD, Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 20386565
  • University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19853370
2009
  • Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, 77239-1439, USA. · Pubmed 19414670
  • Department of Systems Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19244175
  • Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 19855158
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 19652704
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 19551858
  • Department of Genitourinary Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19202079
University of Athens
2019
  • Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, 1881 East Road, Unit 1907, Houston, TX, 77054, USA. · Department of Bioengineering, Rice University, Houston, TX, USA. · Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, 1881 East Road, Unit 1907, Houston, TX, 77054, USA. · Pubmed 29748904
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
2013
  • Department of Clinical Therapeutics, University of Athens Medical School, Athens, Greece. · Pubmed 22753310
2010
  • Department of Genitourinary Medical Oncology and David H Koch Center for Applied Research of Genitourinary Cancers, University of Athens, Athens, Greece. · Pubmed 20145177
Alexandra Hospital Athens
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
Unspecified
2016
  • Michigan Center for Translational Pathology; Department of Pathology; Comprehensive Cancer Center. · Michigan Center for Translational Pathology; Department of Radiation Oncology; Comprehensive Cancer Center. · Department of Urology. · Michigan Center for Translational Pathology; Howard Hughes Medical Institute. · Department of Radiation Oncology. · Department of Genitourinary Medical Oncology; David H. Koch Center for Applied Research of Genitourinary Cancers. · Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry. · Department of Urology; Comprehensive Cancer Center. · Department of Internal Medicine. · Comprehensive Cancer Center; Department of Internal Medicine. · Michigan Center for Translational Pathology; Department of Pathology; Department of Urology; Comprehensive Cancer Center. · Michigan Center for Translational Pathology; Department of Pathology; Department of Urology; Howard Hughes Medical Institute; Comprehensive Cancer Center. Electronic address: · Michigan Center for Translational Pathology; Department of Urology; Comprehensive Cancer Center. · Pubmed 26806347
2015
  • Departments of Genitourinary Medical Oncology. · University of New Mexico Cancer Center and Divisions of Molecular Medicine, and. · David H. Koch Center, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030; · Biostatistics, and. · Pathology and. · Harvard Medical School and Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA 02215; and · University of New Mexico Cancer Center and Divisions of Molecular Medicine, and · University of New Mexico Cancer Center and Divisions of Hematology and Medical Oncology, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131 · Pubmed 25675522
Miscellaneous institutions in Houston
2015
  • Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Department of Internal Medicine, Section of Medical Oncology, UAB Medical Center, Birmingham, AL, USA. · Department of Medicine and Urology, Tulane University, New Orleans, LA, USA. · Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 26153564
25 Other Locations Show
Yearly article counts 26917161116161489
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.